| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.098 | 0.06 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.06 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.3 | 0.06 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.088 | 0.06 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.3 | 0.06 |